An Vermeulen
- Biotechnology top 0.5%
- Listeria monocytogenes in Food Safety 21
- Microbial Inactivation Methods 18
- Food Science top 0.5%
- Biomaterials top 2%
- Psychiatry and Mental health top 2%
- Schizophrenia research and treatment 24
- Pharmaceutical Science top 2%
-
- Antibiotics Pharmacokinetics and Efficacy 25
- Pharmacogenetics and Drug Metabolism 18
-
- Pharmaceutical studies and practices 21
-
- Meat and Animal Product Quality 14
-
- Drug Transport and Resistance Mechanisms 12
- Co-authors
- Frank DevlieghereJohan DebevereMieke UyttendaeleJan Van BocxlaerKim StuyckensMahesh N. SamtaniJan Van ImpeAnnemie Geeraerd
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
An Vermeulen
215 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Biotechnology 626
- Food Science 1.0k
- Biomaterials 677
- Psychiatry and Mental health 620
- Pharmaceutical Science 234
Countries citing papers authored by An Vermeulen
This map shows the geographic impact of An Vermeulen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Vermeulen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Vermeulen more than expected).
Fields of papers citing papers by An Vermeulen
This network shows the impact of papers produced by An Vermeulen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Vermeulen. The network helps show where An Vermeulen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside An Vermeulen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2020 | 5 | |
| 8 | 2019 | 6 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 26 | |
| 11 | 2018 | 27 | |
| 12 | 2018 | 26 | |
| 13 | 2017 | 2 | |
| 14 | Deoxynivalenol-3-β-D-glucoside : in vitro cytotoxicity and in vivo oral bioavailability and hydrolysis in broiler chicken and pig | 2016 | 1 |
| 15 | 2016 | 13 | |
| 16 | 2016 | 13 | |
| 17 | 2015 | 50 | |
| 18 | Predictive models to support manufacturers of processed meat in their compliance with EU regulation 2073/2005 | 2013 | 2 |
| 19 | Photocatalytic degradation of the antibiotic moxifloxacin: a deeper look at the degradation products and residual antibacterial activity | 2013 | 1 |
| 20 | Evaluation of growth/no growth modelling approaches on a non-abrupt growth/no growth interface of Listeria monocytogenes | 2007 | 3 |
About An Vermeulen
An Vermeulen is a scholar working on Biotechnology, Pharmacology and Pharmacology, having authored 222 papers that have together received 5.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Schizophrenia research and treatment (24 papers), Listeria monocytogenes in Food Safety (21 papers), Pharmaceutical studies and practices (21 papers), Pharmacogenetics and Drug Metabolism (18 papers), Microbial Inactivation Methods (18 papers), Meat and Animal Product Quality (14 papers) and Drug Transport and Resistance Mechanisms (12 papers). The work is most often cited by research in Biotechnology (626 citations), Food Science (1.0k citations) and Biomaterials (677 citations). An Vermeulen has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Frank Devlieghere, Johan Debevere, Mieke Uyttendaele, Jan Van Bocxlaer, Kim Stuyckens, Mahesh N. Samtani, Jan Van Impe, Annemie Geeraerd, Robert Paridaens and J.P. Deslypère. Their work appears in journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.